Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR

globenewswire.com
ABT Abbott Laboratories is identified as a leading participant in the Europe Point of Care diagnostics market, which is expected to experience substantial growth. The article does not offer specific sentiment regarding Abbott's individual performance. BIO Bio-Rad Laboratories Inc is mentioned as a leading participant in the Europe Point of Care diagnostics market, which is expected to grow. The article does not provide specific sentiment or performance data for Bio-Rad. QGEN QIAGEN NV is listed as a leading participant in the Europe Point of Care diagnostics market, a sector poised for significant growth. The article does not offer specific sentiment regarding QIAGEN's performance. NDSN Danaher Corp is identified as a leading participant in the Europe Point of Care diagnostics market, which is projected to grow substantially. The article does not provide specific sentiment towards Danaher's individual performance. GILD Gilead Sciences is mentioned for its HIVISION100 initiative in Germany, aiming to increase HIV diagnosis rates. While this initiative supports the market growth, the article does not provide direct sentiment on Gilead's overall performance in the POC diagnostics sector.

Europe Point of Care Diagnostics Market Size and Forecast, 2021 - 2031 | Market to Reach US$21.4 Billion by 2031 as Rapid Testing and Molecular Innovation Drive 13.4% CAGR Dublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- "Europe Point of Care Diagnostics Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis" has been added to ResearchAndMarkets.com's offering.

The Europe Point of Care (POC) Diagnostics Market is projected to increase from US$ 8,939.5 million in 2024 to US$ 21,407.3 million by 2031, registering a compound annual growth rate (CAGR) of 13.4% from 2025 to 2031. Market expansion across the UK, Germany, France, Italy, Spain, and the Rest of Europe is being driven by the growing prevalence of infectious and chronic diseases, increasing demand for rapid diagnostic results, and wider adoption of advanced testing technologies.

Healthcare providers are increasingly using POC diagnostic solutions to support timely clinical decisions, early intervention, and improved disease management. Continued investment in research and development by public and private organizations is accelerating innovation in molecular diagnostics, biosensors, and portable testing platforms. Europe also benefits from an established healthcare infrastructure, a strong manufacturing base, supportive government initiatives, and rising awareness of early disease diagnosis.

Europe POC Diagnostics Market Segmentation

Technology Innovation and Market Outlook

The Europe POC diagnostics market is expected to benefit from continued product development focused on accessibility, affordability, accuracy, and faster results. Molecular testing platforms and portable devices are expanding the availability of diagnostics closer to patients, supporting the broader decentralization of healthcare services.

Recent product launches demonstrate the pace of innovation. In June 2023, Sysmex Corporation introduced a POC testing system designed to detect antimicrobial susceptibility using urine samples from patients suspected of having urinary tract infections. In January 2023, Cipla Limited launched the CE IVD-approved Cippoint device for testing cardiac markers, infectious diseases, metabolic markers, and other parameters. QuantuMDx introduced the Q-POC rapid PCR diagnostic system in July 2021, initially targeting SARS-CoV-2 detection. The system is CE-IVD marked for use in Europe.

Germany Leads the European Market

Germany held the largest share of the Europe POC diagnostics market in 2024. Demand is supported by the country's disease burden and the need for faster detection of cancer, hospital-acquired infections, HIV, and other serious conditions. Approximately 605,805 new cancer cases were reported in Germany in 2022. Public health programs are also encouraging earlier diagnosis, including Gilead Sciences' HIVISION100 initiative, which targeted a 95% HIV diagnosis rate by 2025.

Competitive Landscape

Leading participants in the Europe Point of Care diagnostics market include Siemens AG, Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux SA, Bio-Rad Laboratories Inc, QIAGEN NV, Nova Biomedical Corporation, Polymer Technology Systems, Inc., and Danaher Corp. These companies are strengthening their positions through product innovation, geographic expansion, partnerships, and mergers and acquisitions. Continued investment in advanced diagnostic platforms is expected to improve testing speed and precision while expanding access across healthcare facilities and homecare settings.

Key Topics Covered

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis Formulation

3.2.2 Macroeconomic Factor Analysis

3.2.3 Developing Base Number

3.2.4 Data Triangulation

3.2.5 Country-level Data

4. Point of Care Diagnostics Market Landscape

4.1 PEST Analysis

5. Europe Point of Care Diagnostics Market - Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Point of Care Diagnostics Market - Europe Market Analysis

6.1 Europe Point of Care Diagnostics Market Revenue (US$ Million), 2024 - 2031

6.2 Europe Point of Care Diagnostics Market Forecast and Analysis

7. Europe Point of Care Diagnostics Market Revenue Analysis - by Product

7.1 Glucose Monitoring

7.1.1 Overview

7.1.2 Glucose Monitoring: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.2 Infectious Disease Testing

7.2.1 Overview

7.2.2 Infectious Disease Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.3 Cardio Metabolic Testing

7.3.1 Overview

7.3.2 Cardio Metabolic Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.4 Pregnancy and Fertility Testing

7.4.1 Overview

7.4.2 Pregnancy and Fertility Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.5 Coagulation Testing

7.5.1 Overview

7.5.2 Coagulation Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.6 Tumor or Cancer Marker Testing

7.6.1 Overview

7.6.2 Tumor or Cancer Marker Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.7 Cholesterol Testing

7.7.1 Overview

7.7.2 Cholesterol Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.8 Urinalysis Testing

7.8.1 Overview

7.8.2 Urinalysis Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.9 Hematology Testing

7.9.1 Overview

7.9.2 Hematology Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.10 Thyroid Testing

7.10.1 Overview

7.10.2 Thyroid Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

7.11 Others

7.11.1 Overview

7.11.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Europe Point of Care Diagnostics Market Revenue Analysis - by Glucose Monitoring

8.1 Blood Glucose Meter

8.1.1 Overview

8.1.2 Blood Glucose Meter: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8.2 Lancet

8.2.1 Overview

8.2.2 Lancet: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8.3 Strips

8.3.1 Overview

8.3.2 Strips: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Europe Point of Care Diagnostics Market Revenue Analysis - by Infectious Disease Testing

9.1 HIV Testing

9.1.1 Overview

9.1.2 HIV Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.2 Influenza Testing

9.2.1 Overview

9.2.2 Influenza Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.3 Sexually Transmitted Diseases Testing

9.3.1 Overview

9.3.2 Sexually Transmitted Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.4 Hepatitis C Virus Testing

9.4.1 Overview

9.4.2 Hepatitis C Virus Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.5 Tropical Diseases Testing

9.5.1 Overview

9.5.2 Tropical Diseases Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.6 Respiratory Infection Testing

9.6.1 Overview

9.6.2 Respiratory Infection Testing: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.7 Hospital Acquired Infections

9.7.1 Overview

9.7.2 Hospital Acquired Infections: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9.8 Others

9.8.1 Overview

9.8.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Europe Point of Care Diagnostics Market Revenue Analysis - by Cardio Metabolic Testing

10.1 Cardiac Troponin (cTn) Test

10.1.1 Overview

10.1.2 Cardiac Troponin (cTn) Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10.2 Myoglobin Test

10.2.1 Overview

10.2.2 Myoglobin Test: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10.3 Others

10.3.1 Overview

10.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Europe Point of Care Diagnostics Market Revenue Analysis - by Purchase Mode

11.1 OTC

11.1.1 Overview

11.1.2 OTC: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11.2 Prescription

11.2.1 Overview

11.2.2 Prescription: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Europe Point of Care Diagnostics Market Revenue Analysis - by Sample

12.1 Blood

12.1.1 Overview

12.1.2 Blood: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12.2 Urine

12.2.1 Overview

12.2.2 Urine: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12.3 Others

12.3.1 Overview

12.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Europe Point of Care Diagnostics Market Revenue Analysis - by End User

13.1 Healthcare Facilities

13.1.1 Overview

13.1.2 Healthcare Facilities: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13.2 Homecare

13.2.1 Overview

13.2.2 Homecare: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13.3 Others

13.3.1 Overview

13.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

14. Europe Point of Care Diagnostics Market Revenue Analysis - by Healthcare Facilities

14.1 Hospitals and Clinics

14.1.1 Overview

14.1.2 Hospitals and Clinics: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

14.2 Diagnostic Centers

14.2.1 Overview

14.2.2 Diagnostic Centers: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

14.3 Others

14.3.1 Overview

14.3.2 Others: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15. Europe Point of Care Diagnostics Market - Country Analysis

15.1 Europe

15.1.1 Europe Point of Care Diagnostics Market Revenue, Forecast and Analysis - by Country

15.1.2 United Kingdom

15.1.2.1 United Kingdom: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.2.2 United Kingdom: Europe Point of Care Diagnostics Market Share - by Product

15.1.2.3 United Kingdom: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.2.4 United Kingdom: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.2.5 United Kingdom: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.2.6 United Kingdom: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.2.7 United Kingdom: Europe Point of Care Diagnostics Market Share - by Sample

15.1.2.8 United Kingdom: Europe Point of Care Diagnostics Market Share - by End User

15.1.2.9 United Kingdom: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

15.1.3 Germany

15.1.3.1 Germany: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.3.2 Germany: Europe Point of Care Diagnostics Market Share - by Product

15.1.3.3 Germany: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.3.4 Germany: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.3.5 Germany: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.3.6 Germany: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.3.7 Germany: Europe Point of Care Diagnostics Market Share - by Sample

15.1.3.8 Germany: Europe Point of Care Diagnostics Market Share - by End User

15.1.3.9 Germany: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

15.1.4 France

15.1.4.1 France: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.4.2 France: Europe Point of Care Diagnostics Market Share - by Product

15.1.4.3 France: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.4.4 France: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.4.5 France: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.4.6 France: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.4.7 France: Europe Point of Care Diagnostics Market Share - by Sample

15.1.4.8 France: Europe Point of Care Diagnostics Market Share - by End User

15.1.4.9 France: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

15.1.5 Italy

15.1.5.1 Italy: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.5.2 Italy: Europe Point of Care Diagnostics Market Share - by Product

15.1.5.3 Italy: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.5.4 Italy: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.5.5 Italy: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.5.6 Italy: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.5.7 Italy: Europe Point of Care Diagnostics Market Share - by Sample

15.1.5.8 Italy: Europe Point of Care Diagnostics Market Share - by End User

15.1.5.9 Italy: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

15.1.6 Spain

15.1.6.1 Spain: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.6.2 Spain: Europe Point of Care Diagnostics Market Share - by Product

15.1.6.3 Spain: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.6.4 Spain: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.6.5 Spain: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.6.6 Spain: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.6.7 Spain: Europe Point of Care Diagnostics Market Share - by Sample

15.1.6.8 Spain: Europe Point of Care Diagnostics Market Share - by End User

15.1.6.9 Spain: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

15.1.7 Rest of Europe

15.1.7.1 Rest of Europe: Europe Point of Care Diagnostics Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15.1.7.2 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Product

15.1.7.3 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Glucose Monitoring

15.1.7.4 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Infectious Disease Testing

15.1.7.5 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Cardio Metabolic Testing

15.1.7.6 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Purchase Mode

15.1.7.7 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Sample

15.1.7.8 Rest of Europe: Europe Point of Care Diagnostics Market Share - by End User

15.1.7.9 Rest of Europe: Europe Point of Care Diagnostics Market Share - by Healthcare Facilities

17. Industry Landscape

17.1 Overview

17.2 New Product Development

17.3 Merger and Acquisition

17.4 Other Strategic Developments

18. Company Profiles

18.1 Siemens AG

18.1.1 Key Facts

18.1.2 Business Description

18.1.3 Products and Services

18.1.4 Financial Overview

18.1.5 SWOT Analysis

18.1.6 Key Developments

18.2 Abbott Laboratories

18.2.1 Key Facts

18.2.2 Business Description

18.2.3 Products and Services

18.2.4 Financial Overview

18.2.5 SWOT Analysis

18.2.6 Key Developments

18.3 F. Hoffmann-La Roche Ltd

18.3.1 Key Facts

18.3.2 Business Description

18.3.3 Products and Services

18.3.4 Financial Overview

18.3.5 SWOT Analysis

18.3.6 Key Developments

18.4 bioMerieux SA

18.4.1 Key Facts

18.4.2 Business Description

18.4.3 Products and Services

18.4.4 Financial Overview

18.4.5 SWOT Analysis

18.4.6 Key Developments

18.5 Bio-Rad Laboratories Inc

18.5.1 Key Facts

18.5.2 Business Description

18.5.3 Products and Services

18.5.4 Financial Overview

18.5.5 SWOT Analysis

18.5.6 Key Developments

18.6 QIAGEN NV

18.6.1 Key Facts

18.6.2 Business Description

18.6.3 Products and Services

18.6.4 Financial Overview

18.6.5 SWOT Analysis

18.6.6 Key Developments

18.7 Nova Biomedical Corporation

18.7.1 Key Facts

18.7.2 Business Description

18.7.3 Products and Services

18.7.4 Financial Overview

18.7.5 SWOT Analysis

18.7.6 Key Developments

18.8 Polymer Technology Systems, Inc. (PTS)

18.8.1 Key Facts

18.8.2 Business Description

18.8.3 Products and Services

18.8.4 Financial Overview

18.8.5 SWOT Analysis

18.8.6 Key Developments

18.9 Danaher Corp

18.9.1 Key Facts

18.9.2 Business Description

18.9.3 Products and Services

18.9.4 Financial Overview

18.9.5 SWOT Analysis

18.9.6 Key Developments

19. Appendix

19.1 About the Analyst

List of Tables [59]

List of Figures [56]

For more information about this report visit https://www.researchandmarkets.com/r/9b1lm8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.